CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NABBA project focuses on training early stage researchers in the use of nanoparticles for biomedical applications. It aims to develop innovative drug delivery systems that can overcome biological barriers, enhancing the effectiveness of therapies such as gene therapeutics and recombinant proteins.
Many therapeutic targets are shielded behind biological barriers, limiting the possibility to reach them with conventional drugs or diagnostic probes.
Biological barriers are even more problematic for most biological pharmaceutics, such as recombinant proteins, antibodies and gene therapeutics.
The most promising solution to this challenge is the use of nano-vehicles for specific targeting and delivery.
The aim of NABBA is to form European early stage researchers (ESR) with cutting-edge scientif…
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Utrecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
Spain, Santiago De Compostela
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
